Articles with "isoniazid preventive" as a keyword



Photo by finnnyc from unsplash

Drop‐offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015–2019

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of the International AIDS Society"

DOI: 10.1002/jia2.25939

Abstract: Isoniazid preventive therapy (IPT) can reduce the risk of tuberculosis (TB) in children living with HIV (CLHIV), but data on the outcomes of the IPT cascade in CLHIV are limited. read more here.

Keywords: living hiv; isoniazid preventive; preventive therapy; children living ... See more keywords
Photo by laela from unsplash

Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland

Sign Up to like & get
recommendations!
Published in 2017 at "Medicine"

DOI: 10.1097/md.0000000000007740

Abstract: Abstract Although efficacy of 36 months isoniazid preventive therapy (IPT) among HIV-positive individuals has been proven in trial settings, outcome, tolerance, and adherence have rarely been evaluated in real-life settings. This is a prospective observational… read more here.

Keywords: isoniazid preventive; clinics swaziland; rural clinics; months isoniazid ... See more keywords
Photo from wikipedia

Isoniazid preventive therapy-related adverse events among Malawian adults on antiretroviral therapy: A cohort study

Sign Up to like & get
recommendations!
Published in 2022 at "Medicine"

DOI: 10.1097/md.0000000000030591

Abstract: Adverse events may be a cause of observed poor completion of isoniazid preventive therapy (IPT) among people living with HIV in high tuberculosis burden areas. Data on IPT-related adverse events (AE) from sub-Saharan Africa are… read more here.

Keywords: ipt related; isoniazid preventive; preventive therapy; ipt ... See more keywords
Photo from wikipedia

High burden of adverse drug reactions to Isoniazid Preventive Therapy in people living with HIV at three tertiary hospitals in Uganda: associated factors.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of acquired immune deficiency syndromes"

DOI: 10.1097/qai.0000000000002842

Abstract: BACKGROUND HIV is one of the most important risk factors for TB-related morbidity and mortality. Isoniazid preventive therapy (IPT) is recommended to prevent latent TB reactivation in HIV patients. However, due to multiple therapies and… read more here.

Keywords: isoniazid preventive; ipt; drug reactions; preventive therapy ... See more keywords
Photo from wikipedia

Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study

Sign Up to like & get
recommendations!
Published in 2022 at "Risk Management and Healthcare Policy"

DOI: 10.2147/rmhp.s368315

Abstract: Purpose In Eritrea, a 6-month isoniazid preventive therapy (IPT) was introduced in Eritrea in 2014 to prevent/reduce risk of incident tuberculosis in people living with HIV (PLHIV). The global and local uptake of IPT in… read more here.

Keywords: isoniazid preventive; ipt; study; implementation ... See more keywords
Photo from wikipedia

Assessment of isoniazid preventive therapy in the reduction of tuberculosis among ART patients in Arba Minch Hospital, Ethiopia

Sign Up to like & get
recommendations!
Published in 2017 at "Therapeutics and Clinical Risk Management"

DOI: 10.2147/tcrm.s127765

Abstract: Background Tuberculosis (TB) is the most frequent life-threatening opportunistic disease among people living with HIV and remains a leading cause of mortality, even among persons receiving antiretroviral therapy (ART). Isoniazid preventive therapy (IPT) and cotrimoxazole… read more here.

Keywords: isoniazid preventive; ipt; preventive therapy; tuberculosis ... See more keywords